Artykuły udostępnione publicznie: - Rudolph E TanziWięcej informacji
Niedostępne w żadnym miejscu: 14
Sprawdź
Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial
Huntington Study Group Reach2HD Investigators
The Lancet Neurology 14 (1), 39-47, 2015
Upoważnienia: US National Institutes of Health
Sprawdź
Alzheimer disease risk genes: 29 and counting
L Bertram, RE Tanzi
Nature Reviews Neurology 15 (4), 191-192, 2019
Upoważnienia: German Research Foundation, European Commission
Sprawdź
PLD3 gene variants and Alzheimer's disease
BV Hooli, CM Lill, K Mullin, D Qiao, C Lange, L Bertram, RE Tanzi
Nature 520 (7545), E7-E8, 2015
Upoważnienia: US National Institutes of Health
Sprawdź
Dissecting Alzheimer's disease pathogenesis in human 2D and 3D models
G Cenini, M Hebisch, V Iefremova, LJ Flitsch, Y Breitkreuz, RE Tanzi, ...
Molecular and Cellular Neuroscience 110, 103568, 2021
Upoważnienia: European Commission, Federal Ministry of Education and Research, Germany
Sprawdź
Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models
T Natunen, M Takalo, S Kemppainen, S Leskelä, M Marttinen, ...
Neurobiology of disease 85, 187-205, 2016
Upoważnienia: Academy of Finland
Sprawdź
Identification of novel genes for age‐at‐onset of Alzheimer's disease by combining quantitative and survival trait analyses
YJ Li, K Nuytemans, JO La, R Jiang, SH Slifer, S Sun, A Naj, XR Gao, ...
Alzheimer's & Dementia 19 (7), 3148-3157, 2023
Upoważnienia: US National Institutes of Health
Sprawdź
The Genetic Basis of Alzheimer's Disease: Findings From Genome-Wide Studies
B Hooli, RE Tanzi
Genomics, Circuits, and Pathways in Clinical Neuropsychiatry, 547-571, 2016
Upoważnienia: US National Institutes of Health
Sprawdź
Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in Mice
P Bai, Y Liu, L Yang, W Ding, P Mondal, N Sang, G Liu, X Lu, TT Ho, ...
Journal of Medicinal Chemistry 66 (23), 16075-16090, 2023
Upoważnienia: US National Institutes of Health
Sprawdź
The genetic basis of Alzheimer’s disease
B Hooli, RE Tanzi
Developing therapeutics for alzheimer's disease, 23-37, 2016
Upoważnienia: US National Institutes of Health
Sprawdź
Retromer Proteins Reduced in Down Syndrome and the Dp16 Model: Impact of APP Dose and Preclinical Studies of a γ‐Secretase Modulator
XQ Chen, M Sawa, A Becker, D Karachentsev, X Zuo, KD Rynearson, ...
Annals of Neurology 94 (2), 245-258, 2023
Upoważnienia: US National Institutes of Health
Sprawdź
Bioluminescence Imaging with Functional Amyloid Reservoirs in Alzheimer’s Disease Models
J Yang, W Ding, B Zhu, S Zhen, S Kuang, J Yang, C Zhang, P Wang, ...
Analytical Chemistry 95 (38), 14261-14270, 2023
Upoważnienia: US National Institutes of Health
Sprawdź
The Effect of Pexidartinib on Neuropathic Pain via Influences on Microglia and Neuroinflammation in Mice
L Yang, A Gomm, P Bai, W Ding, RE Tanzi, C Wang, S Shen, C Zhang
Anesthesia & Analgesia, 10.1213, 2022
Upoważnienia: US National Institutes of Health
Sprawdź
Three-Dimensional Cultures of Human Neural Stem Cells: An Application for Modeling Alzheimer’s Disease Pathogenesis
SH Choi, C D’Avanzo, YH Kim, E Bylykbashi, M Hebisch, O Brüstle, ...
Stem Cell Technologies in Neuroscience, 1-18, 2017
Upoważnienia: US National Institutes of Health
Sprawdź
S1‐04–02: Genetic association studies in Alzheimer's disease
RE Tanzi
Alzheimer's & Dementia 4, T105-T105, 2008
Upoważnienia: US National Institutes of Health
Dostępne w jakimś miejscu: 369
Sprawdź
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
JC Lambert, CA Ibrahim-Verbaas, D Harold, AC Naj, R Sims, ...
Nature genetics 45 (12), 1452-1458, 2013
Upoważnienia: US National Institutes of Health, National Institute of Health and Medical …
Sprawdź
Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing
BW Kunkle, B Grenier-Boley, R Sims, JC Bis, V Damotte, AC Naj, ...
Nature genetics 51 (3), 414-430, 2019
Upoważnienia: US National Institutes of Health, Motor Neurone Disease Association, UK, UK …
Sprawdź
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
P Hollingworth, D Harold, R Sims, A Gerrish, JC Lambert, ...
Nature genetics 43 (5), 429-435, 2011
Upoważnienia: US National Institutes of Health, Research Foundation (Flanders), National …
Sprawdź
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ...
Nature genetics 43 (5), 436-441, 2011
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
Sprawdź
Mapping autism risk loci using genetic linkage and chromosomal rearrangements
Nature genetics 39 (3), 319-328, 2007
Upoważnienia: Genome Canada, German Research Foundation
Sprawdź
New insights into the genetic etiology of Alzheimer's disease and related dementias.
Bellenguez
Nat Genet, 2022
Upoważnienia: US National Institutes of Health, Howard Hughes Medical Institute, National …
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy